AGONIST of Tumor necrosis factor receptor superfamily member 5 agonist
Product Description
Giloralimab (anti-CD40) is a potent antiCD40 agonistic monoclonal antibody. Giloralimab (anti-CD40) has the potential for the research of cancer. Purity >95% (SDS-PAGE&SEC) Endotoxin Level < 1.0EU/mg
Product Properties
Isotype
Human IgG1
Light Chain Type
kappa
SDS-PAGE
145 kDa
Purification Method
Protein A purified
Form
Liquid
Concentration
Lot by Lot
Storage Temp
Store at -80°C,Avoid repeated freezing and thawing
Shipped In
Ice chest + Ice pads
Stability And Storage
Store at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
CAS
2226292-20-0
Images
Giloralimab (anti-CD40) (Ab182875) - Flow Cytometry Flow Cytometry analysis of Raji cells labelling CD40 (red) with Giloralimab (anti-CD40) (Ab182875). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Giloralimab (anti-CD40) (Ab182875) - ELISA Immobilized Recombinant Human CD40 protein (rp183577) at 1.0 μg/mL can bind Giloralimab (anti-CD40) (Ab182875) with the EC₅₀ of 25.5 ng/mL.
Giloralimab (anti-CD40) (Ab182875) - SEC The purity of Giloralimab (anti-CD40) (Ab182875) is more than 95% verified by HPLC.
Associated Targets
CD40Tchem Tumor necrosis factor receptor superfamily member 5 0 Activities